Medtronic, GE Healthcare join forces on new-look continuous monitoring solution

Michael Walter | | Cardiovascular Business | Cardiac Surgery
Medtronic and GE Healthcare have received FDA clearance and CE mark approval for a new collaboration designed to improve patient monitoring. The combined solution involves the integration of Medtronic’s INVOS regional oximetry and Microstream capnography technologies into GE Healthcare’s CARESCAPE precision monitoring platform.

Medtronic and GE Healthcare have received U.S. Food and Drug Administration (FDA) clearance and European CE mark approval for a new collaboration designed to improve patient monitoring.

The combined solution involves the integration of Medtronic’s Invos regional oximetry and Microstream capnography technologies into GE Healthcare’s Carescape precision monitoring platform. It tracks the patient before, during and after key procedures, interacting with the electronic medical record (EMR).  

The Invos regional oximetry technology helps track hemodynamic changes and other symptoms of cerebral desaturation events. According to Medtronic, the tool has been associated with helping patients spend much less time in the hospital following coronary artery bypass grafting procedures.

The Microstream capnography technology, meanwhile, monitors patients for signs of declining health and, according to Medtronic, can reduce insignificant alarms by more than 50%.

GE Healthcare’s FlexAcuity technology, designed to help healthcare providers personalize care as needed, is also included in this new offering.

“Medtronic and GE Healthcare are both committed to expanding access to patient care around the world,” Frank Chan, president of Medtronic’s patient monitoring business, said in a statement. “This collaboration brings together our combined medical technology leadership to improve workflow, allowing clinicians more time to focus on what matters most — the patient. Together, we are empowering clinicians with actionable insights to personalize care.”

Related Cardiac Surgery Content:

Transcatheter PVL closure linked to lower 30-day mortality than surgery

Open AAA repair linked to better long-term outcomes than EVAR

New data on cardiac damage before and after AVR suggests earlier treatment may be beneficial

TAVR vs. surgery: A new look at 1-year outcomes among moderate-risk patients with severe, symptomatic AS

When PPE is not enough: Improved shielding during EVAR linked to ‘dramatic reduction’ in radiation exposure

Researchers awarded $1.4M to study heart transplants in children

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

No biopsy required: Blood test could spot signs of rejection in heart transplant recipients
Medtronic’s new ECMO system receives a key approval
Women less likely to receive DCD heart transplants
At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving
Polymer heart valve, the first of its kind to gain commercial approval, linked to positive 1-year data
Female heart surgeons take home much lower salaries

Around the web

Health Exec
Major association of physicians presents itself as a go-to alternative vs. the government on vaccine expertise

One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations. 

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.